Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy

Por Pisanu, M E, Ricci, A, Paris, L, Surrentino, E, Liliac, L, Bagnoli, M, Canevari, S, Mezzanzanica, D, Podo, F, Iorio, E, Canese, R
Publicado em 2014

Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer

Por Granata, A, Nicoletti, R, Tinaglia, V, De Cecco, L, Pisanu, M E, Ricci, A, Podo, F, Canevari, S, Iorio, E, Bagnoli, M, Mezzanzanica, D
Publicado em 2014

Evidence for G-quadruplex in the promoter of VEGFR-2 and its targeting to inhibit tumor angiogenesis

Por Salvati, E., Zizza, P., Rizzo, A., Iachettini, S., Cingolani, C., D'Angelo, C., Porru, M., Randazzo, A., Pagano, B., Novellino, E., Pisanu, M.E., Stoppacciaro, A., Spinella, F., Bagnato, A., Gilson, E., Leonetti, C., Biroccio, A.
Publicado no Nucleic Acids Res (2014)